Revance Therapeutics | DEBITO



DEBITO Cambiamento Data
AbbVie USD 1000K 70.48B 2025-09
ALKERMES USD 71.6M 1.08M 2025-09
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Cara Therapeutics USD 0 0 2025-03
Coherus Biosciences USD 294.92M 1.25M 2025-03
Eli Lilly USD 42.51B 2.6B 2025-09
J&J USD 45.8B 4.97B 2025-09
Merck USD 41.37B 5.97B 2025-09
Neurocrine Biosciences USD 428.4M 10.7M 2025-09
P&G USD 35.95B 483M 2025-09
Pacira USD 376.72M 203.77M 2025-09
Supernus Pharmaceuticals USD 31.77M 531K 2025-06


Revance Therapeutics DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.